Top

Published in:

27-05-2022 | Mastectomy | Review

A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP)

Authors: Parhom Towfighi, Romina Deldar, Zoe K. Haffner, Nathan Aminpour, Olutayo Sogunro, Areeg A. Abu El Hawa, Marc Boisvert, Kenneth L. Fan

Published in: Breast Cancer Research and Treatment | Issue 2/2022

Abstract

Introduction

There is a paucity of literature comparing the postoperative outcomes of males and females with breast cancer who undergo mastectomy. The aim of this study is to evaluate the comorbidities and 30-day post-mastectomy complication rates among males and females.

Methods

We performed a retrospective analysis of breast cancer patients who underwent mastectomy from 2014 to 2016 using the American College of Surgeon's National Surgical Quality Improvement Project database. Data including patient demographics, comorbidities, and 30-day surgical and medical complications were collected. Statistical analysis included Chi-square and Fisher’s exact tests for categorical variables and Student T-tests for continuous variables. Statistical significance was defined as p < 0.05.

Results

A total of 15,167 patients were identified. There were 497 males (3.3%) and 14,670 females (96.7%). Age was significantly higher in females compared to males (63.5 vs. 57.6 years, p < 0.001). Body mass index (BMI) at time of surgery was also higher in males (30.0 vs. 29.3 kg/m², p = 0.011). There was a higher prevalence of diabetes in males (20.1 vs. 16.5%, p = 0.032). Operative duration was significantly longer in females (114.9 vs. 95.0 min, p < 0.001). Median postoperative length of stay was also longer in females (1.2 vs. 0.8 days, p < 0.001). There were no significant differences in 30-day medical or surgical complication rates between the two sexes.

Conclusion

Our findings suggest that differences in age, BMI, and comorbidities between males and females do not significantly impact 30-day medical or surgical complications following total mastectomy for breast cancer. Further research is warranted to identify perioperative risk factors that influence post-mastectomy complication rates.

Level of evidence

3 (Retrospective cohort study)

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660CrossRefPubMed

Burga AM, Fadare O, Lininger RA, Tavassoli FA (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449(5):507–512. https://doi.org/10.1007/s00428-006-0305-3CrossRefPubMedPubMedCentral

Banys-Paluchowski M, Burandt E, Banys J et al (2016) Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: a case report and review of the literature. World J Clin Oncol 7(5):420–424. https://doi.org/10.5306/wjco.v7.i5.420CrossRefPubMedPubMedCentral

White J, Kearins O, Dodwell D, Horgan K, Hanby AM, Speirs V (2011) Male breast carcinoma: increased awareness needed. Breast Cancer Res 13(5):219. https://doi.org/10.1186/bcr2930CrossRefPubMedPubMedCentral

Breast Cancer in Men. American Cancer Society. https://www.cancer.org/cancer/breast-cancer-in-men.html. Accessed 17 Feb 2022

Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998–2005. https://doi.org/10.1056/NEJMoa1206809CrossRefPubMed

Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367(9510):595–604. https://doi.org/10.1016/s0140-6736(06)68226-3CrossRefPubMed

Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678–687. https://doi.org/10.7326/0003-4819-137-8-200210150-00013CrossRefPubMed

Uslukaya Ö, Gümüş M, Gümüş H, Bozdağ Z, Türkoğlu A (2016) The management and outcomes of male breast cancer. J Breast Health 12(4):165–170. https://doi.org/10.5152/tjbh.2016.3073CrossRefPubMedPubMedCentral

10.

Thomas E (2010) Original research: Men's awareness and knowledge of male breast cancer. Am J Nurs 110(10):32–7, 39–40; quiz 41–2. https://doi.org/10.1097/01.NAJ.0000389672.93605.2f

11.

Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811–1814. https://doi.org/10.1093/jnci/djm203CrossRefPubMed

12.

Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25(43):5912–5919. https://doi.org/10.1038/sj.onc.1209877CrossRefPubMed

13.

Brinton LA (2011) Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr 100(6):814–818. https://doi.org/10.1111/j.1651-2227.2010.02131.xCrossRefPubMedPubMedCentral

14.

Dimitrakakis C, Bondy C (2009) Androgens and the breast. Breast Cancer Res 11(5):212. https://doi.org/10.1186/bcr2413CrossRefPubMedPubMedCentral

15.

Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135(7):734–748. https://doi.org/10.1093/oxfordjournals.aje.a116360CrossRefPubMed

16.

Fogh S, Kachnic LA, Goldberg SI, Taghian AG, Powell SN, Hirsch AE (2013) Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Clin Breast Cancer 13(5):344–349. https://doi.org/10.1016/j.clbc.2013.05.004CrossRefPubMed

17.

Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114–2122. https://doi.org/10.1200/jco.2009.25.5729CrossRefPubMedPubMedCentral

18.

Kinne DW (1991) Management of male breast cancer. Oncology (Williston Park) 5(3):45–47 (discussion 47-8)

19.

Eck DL, Koonce SL, Goldberg RF et al (2012) Breast surgery outcomes as quality measures according to the NSQIP database. Ann Surg Oncol 19(10):3212–3217. https://doi.org/10.1245/s10434-012-2529-6CrossRefPubMed

20.

American Medical Association (2007) Surgery: integumentary system. CPT Assist Newslett 17(12):7

21.

American Medical Association (2015) Coding brief: coding for breast surgery. CPT Assist Newslett 25(3):5–11

22.

Coding brief: Coding for breast surery. American Medical Association. https://www.ama-assn.org/practice-management/cpt/cpt-coding-support-latest-guidance-and-best-practices

23.

Karlsson CT, Malmer B, Wiklund F, Grönberg H (2006) Breast cancer as a second primary in patients with prostate cancer–estrogen treatment or association with family history of cancer? J Urol 176(2):538–543. https://doi.org/10.1016/j.juro.2006.03.036CrossRefPubMed

24.

Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97(16):1204–1210. https://doi.org/10.1093/jnci/dji240CrossRefPubMed

25.

Swerdlow AJ, Bruce C, Cooke R et al (2021) Obesity and BREAST CANCER RISK IN MEN: A National Case-Control Study in England and Wales. JNCI Cancer Spectr. https://doi.org/10.1093/jncics/pkab078CrossRefPubMedPubMedCentral

26.

Rifkin WJ, Kantar RS, Cammarata MJ et al (2019) Impact of diabetes on 30-day complications in mastectomy and implant-based breast reconstruction. J Surg Res 235:148–159. https://doi.org/10.1016/j.jss.2018.09.063CrossRefPubMed

27.

Kapoor R, Kumar J, Abhishek, Singh SK (2012) Complications during surgery in chronic kidney disease patients. Clin Queries Nephrol 1(3):241–245. https://doi.org/10.1016/j.cqn.2012.06.008CrossRef

28.

Butterworth J, James R, Prielipp R, Cerese J, Livingston J, Burnett D (2000) Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical Benchmarking Database Participants. Anesthesiology 92(2):414–424. https://doi.org/10.1097/00000542-200002000-00023CrossRefPubMed

29.

Olsen MA, Nickel KB, Fox IK et al (2015) Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol 36(8):907–914. https://doi.org/10.1017/ice.2015.108CrossRefPubMedPubMedCentral

30.

Murphy BL, Glasgow AE, Habermann EB, Hieken TJ (2019) Returns to the operating room after breast surgery at a tertiary care medical center. Am J Surg 218(2):388–392. https://doi.org/10.1016/j.amjsurg.2019.02.026CrossRefPubMed

31.

Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 20(10):3212–3217. https://doi.org/10.1245/s10434-013-3116-1CrossRefPubMed

Title: A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP)
Authors: Parhom Towfighi
Romina Deldar
Zoe K. Haffner
Nathan Aminpour
Olutayo Sogunro
Areeg A. Abu El Hawa
Marc Boisvert
Kenneth L. Fan
Publication date: 27-05-2022
Publisher: Springer US
Keywords: Mastectomy
Breast Cancer
Breast Cancer
Published in: Breast Cancer Research and Treatment / Issue 2/2022
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-022-06628-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Level of evidence

Please log in to get access to this content

Other articles of this Issue 2/2022

Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer

Impact of genomic assays on treatment and outcomes in locally advanced breast cancer

Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort

Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study

Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark

Local and systemic therapy in breast cancer patients with central nervous system metastases

Keynote webinar | Spotlight on antibody–drug conjugates in cancer